Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine

PHASE2CompletedINTERVENTIONAL
Enrollment

1,026

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
MigraineAcute Treatment of Migraine
Interventions
DRUG

Rimegepant

Rimegepant capsules

DRUG

Placebo

Rimegepant placebo-matching capsules

DRUG

Sumatriptan

Rimegepant matching sumatriptan and Rimegepant matching placebo capsules

Trial Locations (41)

13104

Central New York Clinical Research, Manlius

13760

Regional Clinical Research Inc., Endwell

14609

Rochester Clinical Research, Inc., Rochester

19107

Thomas Jefferson University, Philadelphia

19114

Clinical Research Of Philadelphia, Llc, Philadelphia

22304

The Innovative Clinical Research Center, Alexandria

23454

Tidewater Integrated Medical Research, Virginia Beach

27103

Pmg Research Of Winston-Salem, Winston-Salem

27408

Pharmquest, Greensboro

27612

Wake Research Associates, Raleigh

29464

Coastal Carolina Research Center, Inc., Mt. Pleasant

32806

Compass Research, Llc, Orlando

33026

Broward Research Group, Pembroke Pines

33143

Miami Research Associates, Miami

33716

Comprehensive Clinical Development, Inc, St. Petersburg

34471

Renstar Medical Research, Ocala

37421

Clinsearch, Llc, Chattanooga

44195

Cleveland Clinic, Cleveland

45227

Community Research, Cincinnati

48104

Michigan Head Pain And Neurological Institute, Ann Arbor

55402

Clinical Research Institute, Inc., Minneapolis

60642

Diamond Headache Clinic, Ltd., Chicago

63141

Mercy Health Research, St Louis

64114

The Center For Pharmaceutical Research. Pc, Kansas City

65807

Clinvest/ A Division Of Banyan Group, Inc., Springfield

77566

R/D Clinical Research, Inc., Lake Jackson

78705

Premier Research Group Limited, Austin

78731

Futuresearch Trials Of Neurology, Austin

80239

Radiant Research, Inc., Denver

84109

J. Lewis Research, Inc, Salt Lake City

84121

J. Lewis Research, Inc, Salt Lake City

85259

Mayo Clinic Arizona, Scottsdale

85282

Clinical Res. Advantage Inc/ Desert Clinical Research Llc, Tempe

90404

California Medical Clinic For Headache, Santa Monica

91978

Encompass Clinical Research, Spring Valley

94115

University Of California, San Francisco, San Francisco

94598

Diablo Clinical Research, Inc., Walnut Creek

98104

Swedish Pain And Headache Center, Seattle

01757

Milford Emergency Associates, Inc., Milford

02472-3930

Medvadis Research Corporation, Watertown

02886

Omega Medical Research, Warwick

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01430442 - Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine | Biotech Hunter | Biotech Hunter